Chemical cardioversion of atrial fibrillation or flutter with ibutilide inpatients receiving amiodarone therapy

Citation
K. Glatter et al., Chemical cardioversion of atrial fibrillation or flutter with ibutilide inpatients receiving amiodarone therapy, CIRCULATION, 103(2), 2001, pp. 253-257
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
103
Issue
2
Year of publication
2001
Pages
253 - 257
Database
ISI
SICI code
0009-7322(20010116)103:2<253:CCOAFO>2.0.ZU;2-O
Abstract
Backgrould-Ibutilide is a class III drug that is used for the cardioversion of atrial arrhythmias, but it can cause torsade de pointes. Amiodarone als o prolongs the QT interval but rarely causes torsade de pointes. There are no studies in which the concomitant use of the 2 agents was examined. The p urpose of the present study was to assess the efficacy and safety of cardio version with combination therapy in patients with atrial fibrillation or fl utter. Methods ann Results-The study included 70 patients who were treated with lo ng-term oral amiodarone and were referred for elective cardioversion of atr ial fibrillation (57 of 70, 81%) or flutter (13 of 70, 19%). Patients were taking amiodarone (153+/-259 days, mean+/-SD) and were administered 2 mg in travenous ibutilide. Left ventricular ejection fraction was measured with e chocardiography. The QT intervals were measured on 12-lead EGG. Fifty-five patients (79%) had structural heart disease. Patients were in arrhythmia fo r 196+/-508 days before cardioversion, with a left ventricular ejection fra ction of 50+/-11%. In patients with atrial fibrillation, 22 (39%) of 57 and 7 (54%) of 13 patients with flutter converted within 30 minutes of infusio n. Thirty-nine patients who did not convert after ibutilide were treated wi th electrical cardioversion, and 35 (90%) of 39 patients were successfully converted. The QT intervals were further prolonged after ibutilide for the group from 371+/-61 to 479+/-92 ms (P<0.001). There was 1 episode of nonsus tained torsade de pointes (I of 70, 1.4%) after ibutilide. Conclusions-The use of ibutilide converted 54% of patients with atrial flut ter and 39% Of patients with atrial fibrillation who were treated with long -term amiodarone, Despite QT-interval prolongation after ibutilide, only 1 episode of torsade de pointes occurred. Our observations suggest that combi nation therapy may be a useful cardioversion method for chronic atrial fibr illation or flutter.